Vasopressin is a systemic vasoconstrictor. Its pulmonary vasodilatory effect is controversial, and limited data are available on its use in neonates with pulmonary hypertension. Hypothesizing that the ...

Patients with vasodilatory shock, characterized by peripheral vasodilatation and low arterial blood pressure, who do not respond to vasopressors (catecholamines or vasopressin) have a poor prognosis.

A research group led by Associate Professor Takashi Kikuchi and Professor Wei Li from the Department of Pharmacognosy at the Faculty of Pharmaceutical Sciences, Toho University, along with Professor ...